Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹M.D. Bozyaka Training and Research Hospital, Eye Clinic, Izmir/TURKEY
²M.D. Sifa Univercity Medical Faculty, Department of Ophthalmology, Izmir/TURKEY
³M.D. Asistant Professor, Sifa Univercity Medical Faculty, Department of Ophthalmology, Izmir/TURKEY
⁴M.D. Associate Professor, Bozyaka Training and Research Hospital, Eye Clinic, Izmir/TURKEY Nonarteritic anterior ischaemic optic neuropathy (NAION) is the most common acute opticneuropathy in people older than 50 years. The clinic condition is caused by infarction of the laminar or retrolaminar portion of the optic nerve head supplied by the short posterior ciliary arteries. The underlying aetiology and pathophysiology is poorly elucidated.Most treatments proposed for NAION are empirical and include a wide spectrum of agents presumed to effect on thrombosis, on the blood vessels, on the disc edema, or on the neuroprotection. Currently, there is no proven effective long-term treatment for this disorder. The aim of this review is to discuss the traditional treatment methods and current innovations in the nonarteritic ischemic optic neuropathy. Keywords : Ischemia, nonarteritic anterior ischaemic optic neuropathy, neuroprotection, steroid